Towards lipidomics of low-abundant species for exploring tumor heterogeneity guided by high-resolution mass spectrometry imaging

International Journal of Molecular Sciences

Volumn 14, Issue 12, 2013, Pages 24560-24580

  Cimino, Jonathan ^a   Calligaris, David ^a,b   Far, Johann ^a   Debois, Delphine ^a   Blacher, Silvia ^a   Sounni, Nor Eddine ^a   Noel, Agnès ^a   De Pauw, Edwin ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cancer; FTICR mass spectrometry; Hypoxia; Lipidomics; Maldi mass spectrometry imaging; Necrosis

Indexed keywords

CD45 ANTIGEN; KI 67 ANTIGEN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID;

ALGORITHM; ARTICLE; CANCER GROWTH; CELL HETEROGENEITY; CELL SUSPENSION; COLLISIONALLY ACTIVATED DISSOCIATION; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NECROSIS; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MCF-7 CELLS; MICE; MICE, NUDE; PHOSPHOLIPIDS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84890447190     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141224560     Document Type: Article

References (59)

1. Shevchenko, A.; Simons, K. Lipidomics: Coming to grips with lipid diversity. Nat. Rev. 2010, 11, 593-598.
2. Kasson, P.M.; Pande, V.S. Control of membrane fusion mechanism by lipid composition: Predictions from ensemble molecular dynamics. PLoS Comput. Boil. 2007, 3, e220.
3. Aguilar, P.S.; Heiman, M.G.; Walther, T.C.; Engel, A.; Schwudke, D.; Gushwa, N.; Kurzchalia, T.; Walter, P. Structure of sterol aliphatic chains affects yeast cell shape and cell fusion during mating. Proc. Natl. Acad. Sci. USA 2010, 107, 4170-4175.
4. Fujimoto, K.; Iwasaki, C.; Kawaguchi, H.; Yasugi, E.; Oshima, M. Cell membrane dynamics and the induction of apoptosis by lipid compounds. FEBS Lett. 1999, 446, 113-116.
5. Johansen, J.; Ramanathan, V.; Beh, C.T. Vesicle trafficking from a lipid perspective: Lipid regulation of exocytosis in Saccharomyces cerevisiae. Cell. Logist. 2012, 2, 151-160.
6. Janda, M.; Planchais, S.; Djafi, N.; Martinec, J.; Burketova, L.; Valentova, O.; Zachowski, A.; Ruelland, E. Phosphoglycerolipids are master players in plant hormone signal transduction. Plant Cell Rep. 2013, 32, 839-851.
7. Amstalden van Hove, E.R.; Blackwell, T.R.; Klinkert, I.; Eijkel, G.B.; Heeren, R.M.; Glunde, K. Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models. Cancer Res. 2010, 70, 9012-9021.
8. Filippov, V.; Song, M.A.; Zhang, K.; Vinters, H.V.; Tung, S.; Kirsch, W.M.; Yang, J.; Duerksen-Hughes, P.J. Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases. J. Alzheimers Dis. 2012, 29, 537-547.
9. Bennett, S.A.; Valenzuela, N.; Xu, H.; Franko, B.; Fai, S.; Figeys, D. Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's disease. Front. Physiol. 2013, doi:10.3389/fphys.2013.00168.
10. Pellieux, C.; Montessuit, C.; Papageorgiou, I.; Pedrazzini, T.; Lerch, R. Differential effects of high-fat diet on myocardial lipid metabolism in failing and nonfailing hearts with angiotensin II-mediated cardiac remodeling in mice. Am. J. Physiol. Heart Circ. Physiol. 2012, 302, 1795-1805.
11. Minkler, P.E.; Hoppel, C.L. Separation and characterization of cardiolipin molecular species by reverse-phase ion pair high-performance liquid chromatography-mass spectrometry. J Lipid Res. 2010, 51, 856-865.
12. Barber, M.N.; Risis, S.; Yang, C.; Meikle, P.J.; Staples, M.; Febbraio, M.A.; Bruce, C.R. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS One 2012, 7, e41456.
13. Wenk, M.R. Lipidomics: New tools and applications. Cell 2010, 143, 888-895.
14. Kimura, K.; Yamaoka, M.; Kamisaka, Y. Rapid estimation of lipids in oleaginous fungi and yeasts using Nile red fluorescence. J. Microbiol. Methods 2004, 56, 331-338.
15. Van Goor, H.; Gerrits, P.O.; Grond, J. The application of lipid-soluble stains in plastic-embedded sections. Histochemistry 1986, 85, 251-253.
16. Govender, T.; Ramanna, L.; Rawat, I.; Bux, F. BODIPY staining, an alternative to the Nile Red fluorescence method for the evaluation of intracellular lipids in microalgae. Bioresour. Technol. 2012, 114, 507-511.
17. Cooper, M.S.; Hardin, W.R.; Petersen, T.W.; Cattolico, R.A. Visualizing "green oil" in live algal cells. J. Biosci. Bioeng. 2010, 109, 198-201.
18. Wenk, M.R. The emerging field of lipidomics. Nat. Rev. Drug. Discov. 2005, 4, 594-610.
19. Sparvero, L.J.; Amoscato, A.A.; Dixon, C.E.; Long, J.B.; Kochanek, P.M.; Pitt, B.R.; Bayir, H.; Kagan, V.E. Mapping of phospholipids by MALDI imaging (MALDI-MSI): Realities and expectations. Chem. Phys. Lipids 2012, 165, 545-562.
20. Berry, K.A.; Hankin, J.A.; Barkley, R.M.; Spraggins, J.M.; Caprioli, R.M.; Murphy, R.C. MALDI imaging of lipid biochemistry in tissues by mass spectrometry. Chem. Rev. 2011, 111, 6491-6512.
21. Chen, Y.; Allegood, J.; Liu, Y.; Wang, E.; Cachon-Gonzalez, B.; Cox, T.M.; Merrill, A.H., Jr.; Sullards, M.C. Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease. Anal. Chem. 2008, 80, 2780-2788.
22. Murphy, R.C.; Hankin, J.A.; Barkley, R.M. Imaging of lipid species by MALDI mass spectrometry. J. Lipid Res. 2009, 50, 317-322.
23. Bure, C.; Ayciriex, S.; Testet, E.; Schmitter, J.M. A single run LC-MS/MS method for phospholipidomics. Anal. Bioanal. Chem. 2013, 405, 203-213.
24. Vichi, S.; Cortes-Francisco, N.; Caixach, J. Ultrahigh resolution mass spectrometry and accurate mass measurements for high-throughput food lipids profiling. J. Mass Spectrom. 2012, 47, 1177-1190.
25. Jove, M.; Ayala, V.; Ramirez-Nunez, O.; Serrano, J.C.; Cassanye, A.; Arola, L.; Caimari, A.; del Bas, J.M.; Crescenti, A.; Pamplona, R.; et al. Lipidomic and metabolomic analyses reveal potential plasma biomarkers of early atheromatous plaque formation in hamsters. Cardiovasc. Res. 2013, 97, 642-652.
26. Schuhmann, K.; Almeida, R.; Baumert, M.; Herzog, R.; Bornstein, S.R.; Shevchenko, A. Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching between acquisition polarity modes. J. Mass Spectrom. 2012, 47, 96-104.
27. Schuhmann, K.; Herzog, R.; Schwudke, D.; Metelmann-Strupat, W.; Bornstein, S.R.; Shevchenko, A. Bottom-up shotgun lipidomics by higher energy collisional dissociation on LTQ Orbitrap mass spectrometers. Anal. Chem. 2011, 83, 5480-5487.
28. Chaurand, P.; Cornett, D.S.; Angel, P.M.; Caprioli, R.M. From whole-body sections down to cellular level, multiscale imaging of phospholipids by MALDI mass spectrometry. Mol. Cell. Proteomics 2011, 10, doi:10.1074/mcp.O110.004259.
29. Thomas, A.; Charbonneau, J.L.; Fournaise, E.; Chaurand, P. Sublimation of new matrix candidates for high spatial resolution imaging mass spectrometry of lipids: Enhanced information in both positive and negative polarities after 1,5-diaminonapthalene deposition. Anal. Chem. 2012, 84, 2048-2054.
30. Horn, P.J.; Korte, A.R.; Neogi, P.B.; Love, E.; Fuchs, J.; Strupat, K.; Borisjuk, L.; Shulaev, V.; Lee, Y.J.; Chapman, K.D. Spatial mapping of lipids at cellular resolution in embryos of cotton. Plant cell 2012, 24, 622-636.
31. Vance, J.E. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: Two metabolically related aminophospholipids. J. Lipid Res. 2008, 49, 1377-1387.
32. Tyurin, V.A.; Tyurina, Y.Y.; Ritov, V.B.; Lysytsya, A.; Amoscato, A.A.; Kochanek, P.M.; Hamilton, R.; Dekosky, S.T.; Greenberger, J.S.; Bayir, H.; et al. Oxidative lipidomics of apoptosis: Quantitative assessment of phospholipid hydroperoxides in cells and tissues. Methods Mol. Boil. 2010, 610, 353-374.
33. Mock, J.N.; Taliaferro, J.P.; Lu, X.; Patel, S.K.; Cummings, B.S.; Long, T.E. Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer. Bioorg. Med. Chem. Lett. 2012, 22, 4854-4858.
34. Girotti, A.W. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J. Lipid Res. 1998, 39, 1529-1542.
35. Guijas, C.; Astudillo, A.M.; Gil-de-Gomez, L.; Rubio, J.M.; Balboa, M.A.; Balsinde, J. Phospholipid sources for adrenic acid mobilization in RAW 264.7 macrophages. Comparison with arachidonic acid. Biochim. Biophys. Acta 2012, 1821, 1386-1393.
36. Feige, E.; Mendel, I.; George, J.; Yacov, N.; Harats, D. Modified phospholipids as anti-inflammatory compounds. Curr. Opin. Lipidol. 2010, 21, 525-529.
37. Damnjanovic, Z.; Jovanovic, M.; Nagorni, A.; Radojkovic, M.; Sokolovic, D; Damnjanovic, G.; Djindjic, B.; Smiljkovic, I.; Kamenov, A.; Damnjanovic, I. Correlation of inflammation parameters and biochemical markers of cholestasis with the intensity of lipid peroxidation in patients with choledocholithiasis. Vojnosanit. Pregl. 2013, 70, 170-176.
38. Simoes, C.; Silva, A.C.; Domingues, P.; Laranjeira, P.; Paiva, A.; Domingues, M.R. Modified phosphatidylethanolamines induce different levels of cytokine expression in monocytes and dendritic cells. Chem. Phys. Lipids 2013, 175-176, 57-64.
39. Leibundgut, G.; Scipione, C.; Yin, H.; Schneider, M.; Boffa, M.B.; Green, S.; Yang, X.; Dennis, E.A.; Witztum, J.L.; Koschinsky, M.L.; Tsimikas, S. Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a). J. Lipid Res. 2013, 54, 2815-2830.
40. Shan, X.; Wang, D.; Chen, J.; Xiao, X.; Jiang, Y.; Wang, Y.; Fan, Y. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer. J. Comput. Assist. Tomogr. 2013, 37, 22-28.
41. Kim, K.; Park, W.Y.; Kim, J.Y.; Sol, M.Y.; Shin, D.H.; Park, D.Y.; Lee, C.H.; Lee, J.H.; Choi, K.U. Prognostic relevance of the expression of CA IX, GLUT-1, and VEGF in ovarian epithelial cancers. Korean J. Pathol. 2012, 46, 532-540.
42. Doria, M.L.; Cotrim, C.Z.; Simoes, C.; Macedo, B.; Domingues, P.; Domingues, M.R.; Helguero, L.A. Lipidomic analysis of phospholipids from human mammary epithelial and breast cancer cell lines. J. cell. Physiol. 2012, 228, 457-468.
43. Monteggia, E.; Colombo, I.; Guerra, A.; Berra, B. Phospholipid distribution in murine mammary adenocarcinomas induced by activated neu oncogene. Cancer Detect. Prev. 2000, 24, 207-211.
44. Dueck, D.A.; Chan, M.; Tran, K.; Wong, J.T.; Jay, F.T.; Littman, C.; Stimpson, R.; Choy, P.C. The modulation of choline phosphoglyceride metabolism in human colon cancer. Mol. Cell. Biochem. 1996, 162, 97-103.
45. Ruiz-Cabello, J.; Cohen, J.S. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 1992, 5, 226-233.
46. Zhang, X.H.; Zhao, C.; Seleznev, K.; Song, K.; Manfredi, J.J.; Ma, Z.A. Disruption of G1-phase phospholipid turnover by inhibition of Ca2+-independent phospholipase A2 induces a p53-dependent cell-cycle arrest in G1 phase. J. Cell Sci. 2006, 119, 1005-1015.
47. Schifferer, R.; Liebisch, G.; Bandulik, S.; Langmann, T.; Dada, A.; Schmitz, G. ApoA-I induces a preferential efflux of monounsaturated phosphatidylcholine and medium chain sphingomyelin species from a cellular pool distinct from HDL(3) mediated phospholipid efflux. Biochim. Biophys. Acta 2007, 1771, 853-863.
48. Li, Z.; Agellon, L.B.; Allen, T.M.; Umeda, M.; Jewell, L.; Mason, A.; Vance, D.E. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 2006, 3, 321-331.
49. Maciel, E.; Domingues, P.; Domingues, M.R. Liquid chromatography/tandem mass spectrometry analysis of long-chain oxidation products of cardiolipin induced by the hydroxyl radical. Rapid Commun. Mass Spectrom. 2013, 25, 316-326.
50. Stubiger, G.; Aldover-Macasaet, E.; Bicker, W.; Sobal, G.; Willfort-Ehringer, A.; Pock, K.; Bochkov, V.; Widhalm, K.; Belgacem, O. Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS/MS. Atherosclerosis 2012, 224, 177-186.
51. Uhl, O.; Glaser, C.; Demmelmair, H.; Koletzko, B. Reversed phase LC/MS/MS method for targeted quantification of glycerophospholipid molecular species in plasma. J. Chromatogr. B 2011, 879, 3556-3564.
52. Murphy, R.C.; Fiedler, J.; Hevko, J. Analysis of nonvolatile lipids by mass spectrometry. Chem. Rev. 2001, 101, 479-526.
53. Kind, T.; Liu, K.H.; Lee, D.Y.; DeFelice, B.; Meissen, J.K.; Fiehn, O. LipidBlast in silico tandem mass spectrometry database for lipid identification. Nat. Methods 2013, 10, 755-758.
54. Knochenmuss, R.; Dubois, F.; Dale, M.J.; Zenobi, R. The matrix suppression effect and ionization mechanisms in matrix-assisted laser desorption/ionization. Rapid Commun. Mass Spectrom. 1996, 10, 871-877.
55. Chan, T.-W.D.; Colburn, A.W.; Derrick, P.J. Matrix-assisted UV laser desorption. Suppression of the matrix peaks. J. Mass Spectrom. 1991, 26, 342-344.
56. Marusyk, A.; Almendro, V.; Polyak, K. Intra-tumour heterogeneity: A looking glass for cancer? Nat. Rev. Cancer 2012, 12, 323-334.
57. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674.
58. Sud, M.; Fahy, E.; Cotter, D.; Brown, A.; Dennis, E.A.; Glass, C.K.; Merrill, A.H., Jr.; Murphy, R.C.; Raetz, C.R.; Russell, D.W.; et al. LMSD: LIPID MAPS structure database. Nucleic Acids Res. 2007, 35, 527-532.
59. Folch, J.; Lees, M.; Sloane Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Boil. Chem. 1957, 226, 497-509.